| Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ... Science 372 (6538), eabg3055, 2021 | 2497 | 2021 |
| Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 1087 | 2021 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1073 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 806 | 2022 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 766* | 2021 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 739 | 2021 |
| Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021 | 557 | 2021 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 424 | 2021 |
| Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK L Du Plessis, JT McCrone, AE Zarebski, V Hill, C Ruis, B Gutierrez, ... Science 371 (6530), 708-712, 2021 | 368 | 2021 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 338 | 2021 |
| Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ... Eurosurveillance 25 (32), 2001410, 2020 | 256 | 2020 |
| The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages DP Martin, S Weaver, H Tegally, JE San, SD Shank, E Wilkinson, ... Cell 184 (20), 5189-5200. e7, 2021 | 251 | 2021 |
| Human adaptation of Ebola virus during the West African outbreak RA Urbanowicz, CP McClure, A Sakuntabhai, AA Sall, G Kobinger, ... Cell 167 (4), 1079-1087. e5, 2016 | 217 | 2016 |
| Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33 AW Tarr, AM Owsianka, JM Timms, PC McClure, RJP Brown, TP Hickling, ... Hepatology 43 (3), 592-601, 2006 | 214 | 2006 |
| Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic B Jackson, MF Boni, MJ Bull, A Colleran, RM Colquhoun, AC Darby, ... Cell 184 (20), 5179-5188. e8, 2021 | 206 | 2021 |
| Tracking the international spread of SARS-CoV-2 lineages B. 1.1. 7 and B. 1.351/501Y-V2 with grinch Á O'Toole, V Hill, OG Pybus, A Watts, II Bogoch, K Khan, JP Messina, ... Wellcome Open Research 6, 2021 | 185 | 2021 |
| An integrated national scale SARS-CoV-2 genomic surveillance network T COVID The Lancet. Microbe 1 (3), e99, 2020 | 175 | 2020 |
| Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B. 1.1. 7 emergence MUG Kraemer, V Hill, C Ruis, S Dellicour, S Bajaj, JT McCrone, G Baele, ... Science 373 (6557), 889-895, 2021 | 146 | 2021 |
| Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England S Mishra, S Mindermann, M Sharma, C Whittaker, TA Mellan, T Wilton, ... EClinicalMedicine 39, 2021 | 118 | 2021 |
| Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021 | 115 | 2021 |
Jonathan BallLSTM and University of NottinghamVerified email at LSTMed.ac.uk
